You are here

Recent Advances

January 30, 2018
Katie Pollard, Gladstone senior investigator

Scientists examine the fastest changing regions in the human genome to learn how our species evolved

January 30, 2018

Scientists examine the fastest changing regions in the human genome to learn how our species evolved

October 20, 2017
Scientists get $8.5M for HIV research

Scientists receive $8.5M in funding to accelerate progress towards a cure for HIV

September 5, 2017
Gladstone Investigators Katherine Pollard and Shomyseh Sanjabi

An unexpected collaboration leads to the discovery of an early predictor of IBD

September 5, 2017

An unexpected collaboration leads to the discovery of an early predictor of IBD

February 8, 2017
Katherine Pollard, PhD, Director, Gladstone Insitutes

Katherine Pollard, PhD, director of the convergence science initiative at the Gladstone Institutes, has been selected as a Chan Zuckerberg Investigator.

December 12, 2016
Dr. Katie Pollard

Katherine Pollard’s expertise, success, and vision fueled her promotion to director of Gladstone’s Convergence Zone.

October 25, 2016
Dr. Nevan Krogan

Researchers at the Gladstone Institutes and UCSF have used a newly developed gene-editing system to find gene mutations that make human immune cells resistant to HIV infection.


October 18, 2016

SAN FRANCISCO, CA—Direct microbial sequencing of environmental samples, such as from ocean water, hospital surfaces, and the human gut, have illuminated the vast number of microbes present in our world.

June 23, 2016

Researchers at Maastricht University and the Gladstone Institutes tackled the challenge of improving the integration of disparate sources and types of data and advance scientists’ understanding of disease.

May 23, 2016
Katherine Pollard

The White House invited Katherine Pollard to join the National Microbiome Initiative as a leader in the field of bioinformatics.  

May 13, 2016
Drs. Katherine Pollard and Nevan Krogan

In their pursuit of cures for debilitating diseases, Gladstone scientists are approaching precision medicine from new angles, researching the microbiome and protein networks that are critical for human biology.

April 4, 2016
Dr. Katherine Pollard

Katherine Pollard’s lab has invented a novel way to read and interpret the human genome. This technology opens the door to identifying drug targets that could treat genetic diseases.

January 15, 2016

Katherine Pollard shares science on big data and high-performance computing with an audience at Google as part of the Gladstone Open Classroom Talks series.

November 17, 2015
Dr. Katie Pollard

The most influential “organ” in the human body is made up of foreign cells—six pounds worth of microorganisms. Katherine Pollard studies the human microbiome to learn how it influences health and disease.

September 22, 2015
Drs. Srivastava, Bruneau, and Pollard

Gladstone has received funding from the National Institutes of Health to continue and expand two exciting projects in cardiovascular research. The funding, totaling more than $6.8 million, supports two teams of scientists and their research on congenital heart disease.

March 4, 2015

SAN FRANCISCO, CA—Several recent science studies have claimed that the gut microbiome—the diverse array of bacteria that live in the stomach and intestines—may be to blame for obesity. But Katherine Pollard, PhD, a senior investigator at the Gladstone Institutes, says it is not that simple.

March 31, 2015

Collaborations have been key to Gladstone’s scientific success since its founding, and its community believes that the biggest challenges in science are better met by bringing together researchers with diverse backgrounds.

June 13, 2012

SAN FRANCISCO, CA—Scientists at the Gladstone Institutes today are announcing their role in an unprecedented collaboration organized by the National Institutes of Health, which used groundbreaking methods to vastly improve our understanding of bacteria that reside in and on the human body.

November 11, 2013

SAN FRANCISCO, CA—What does it mean to be human? According to scientists the key lies, ultimately, in the billions of lines of genetic code that comprise the human genome. The problem, however, has been deciphering that code.